Media Center Banner

NEWS RELEASE

Released: April 11, 2012

Defense Health Program
Department of Defense Peer Reviewed Cancer Research Program
Funding Opportunities for Fiscal Year 2012

The Fiscal Year 2012 (FY12) Defense Appropriation Act provides for $12.8 million (M) to the Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC). The funds provided are directed to be used to conduct research for the following topic areas:

  • Blood cancers
  • Colorectal cancer
  • Genetic cancer research
  • Kidney cancer
  • Listeria vaccine for cancer
  • Melanoma and other skin cancers
  • Mesothelioma
  • Pancreatic cancer
  • Pediatric brain tumors

The program is administered by the USAMRMC through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

FY12 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website by early May 2012.

Award Mechanism Eligibility Key Mechanism Elements Funding
Visionary Postdoctoral Fellowship Award
  • Principal Investigator: M.D./Ph.D. graduate with a total of less than 4 years of postdoctoral research experience
  • Mentor(s): Independent investigator at the level of Assistant Professor or equivalent at the time of the award
  • Research must be in one or more of the FY12 PRCRP Topic Areas
  • Supports training of postdoctoral fellow in the laboratory of an early-career investigator (mentor) with expertise in one or more of the FY12 PRCRP Topic Areas
  • Supports training of postdoctoral fellow to include a budget option for research supplies
  • Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
  • Preliminary data not required
  • Clinical trials will not be supported
  • Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 3 years
Career Development Award Principal Investigator: Independent investigator at the level of Assistant Professor or equivalent at the time of the award
  • Research with emphasis in discovery must be in one or more of the FY12 PRCRP Topic Areas
  • Supports investigator in the early stages of their career
  • Applications must not address breast, prostate, lung (excluding mesothelioma), or ovarian cancer research
  • Preliminary data not required
  • Clinical trials will not be supported
  • Maximum funding for the entire period of performance is $240,000 for direct costs (plus indirect costs)
  • Maximum period of performance is 2 years

Information in this pre-announcement is being provided to allow investigators time to plan and develop proposals. All proposals must conform to the final Program Announcement and General Application Instructions (including deadlines) that will be available for electronic downloading from the Grants.gov website in early May 2012. The application package containing the required forms for each award mechanism will also be found on Grants.gov.

A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to proposal submission. Applications must be submitted through the federal government's single-entry portal, Grants.gov.

Requests for email notification regarding release of the Program Announcements may be sent to help@cdmrp.org. For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:

CDMRP Public Affairs
301-619-9783
CDMRP.PublicAffairs@amedd.army.mil